The Follow-Up of Biomarkers Better Predicts the Poor Outcome in COVID-19 Patients
dc.contributor.author | Basoglu, Ozen K. | |
dc.contributor.author | Ozhan, Mustafa Hikmet | |
dc.contributor.author | Ekren, Pervin Korkmaz | |
dc.contributor.author | Ak, Gunes | |
dc.contributor.author | Tasbakan, Mehmet Sezai | |
dc.contributor.author | Sayiner, Abdullah | |
dc.date.accessioned | 2021-05-03T20:36:56Z | |
dc.date.available | 2021-05-03T20:36:56Z | |
dc.date.issued | 2020 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Objective. To investigate the course of biomarkers on admission and follow-up in order to identify early predictors for poor outcome in COVID-19 patients. Methods. in this study, 132 COVID-19 patients were classified as good outcome (n=62) and poor outcome (n=70) groups. Laboratory parameters were evaluated on admission and within 5-7 days after hospitalization. Results. Baseline levels of neutrophil-lymphocyte ratio, CRP, procalcitonin, ferritin, D-dimer and LDH were higher (p<0.01); lymphocyte count was lower in the poor outcome patients. During follow-up there was a larger decrease in lymphocyte count and more prominent increases in other biomarkers (p<0.001). in ROC analysis, the AUCs strongly indicated the poor outcome on days 5-7 of the hospitalization. Conclusions. This study suggests that the follow-up measurements of the biomarkers better predict the poor outcome in COVID-19 pneumonia. | en_US |
dc.identifier.endpage | 851 | en_US |
dc.identifier.issn | 0091-7370 | |
dc.identifier.issn | 1550-8080 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 33334804 | en_US |
dc.identifier.startpage | 848 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/70276 | |
dc.identifier.volume | 50 | en_US |
dc.identifier.wos | WOS:000599944900021 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Assoc Clinical Scientists | en_US |
dc.relation.ispartof | Annals of Clinical and Laboratory Science | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | biomarkers | en_US |
dc.subject | viral pneumonia | en_US |
dc.subject | prognosis | en_US |
dc.subject | clinical outcome | en_US |
dc.title | The Follow-Up of Biomarkers Better Predicts the Poor Outcome in COVID-19 Patients | en_US |
dc.type | Article | en_US |